Prostate-specific antigen–based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force

JJ Fenton, MS Weyrich, S Durbin, Y Liu, H Bang… - Jama, 2018 - jamanetwork.com
Importance Prostate cancer is the second leading cause of cancer death among US men.
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …

Complications after systematic, random, and image-guided prostate biopsy

M Borghesi, H Ahmed, R Nam, E Schaeffer… - European urology, 2017 - Elsevier
Context Prostate biopsy (PB) represents the gold standard method to confirm the presence
of cancer. In addition to traditional random or systematic approaches, a magnetic resonance …

Screening for prostate cancer: US Preventive Services Task Force recommendation statement

DC Grossman, SJ Curry, DK Owens… - Jama, 2018 - jamanetwork.com
Importance In the United States, the lifetime risk of being diagnosed with prostate cancer is
approximately 11%, and the lifetime risk of dying of prostate cancer is 2.5%. The median age …

[HTML][HTML] Systematic review of complications of prostate biopsy

S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton… - European urology, 2013 - Elsevier
Context Prostate biopsy is commonly performed for cancer detection and management. The
benefits and risks of prostate biopsy are germane to ongoing debates about prostate cancer …

Screening for prostate cancer: US Preventive Services Task Force recommendation statement

VA Moyer… - Annals of internal …, 2012 - acpjournals.org
Description: Update of the 2008 US Preventive Services Task Force (USPSTF)
recommendation statement on screening for prostate cancer. Methods: The USPSTF …

[HTML][HTML] Screening and prostate-cancer mortality in a randomized European study

FH Schröder, J Hugosson, MJ Roobol… - New England journal …, 2009 - Mass Medical Soc
Background The European Randomized Study of Screening for Prostate Cancer was
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen …

[HTML][HTML] Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis

B Pang, Y Zhu, J Ni, J Thompson, D Malouf, J Bucci… - Theranostics, 2020 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is a leading cause of cancer death for males in western countries.
The current gold standard for PCa diagnosis-template needle biopsies-often does not …

Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force

R Chou, JM Croswell, T Dana, C Bougatsos… - Annals of internal …, 2011 - acpjournals.org
Background: Screening can detect prostate cancer at earlier, asymptomatic stages, when
treatments might be more effective. Purpose: To update the 2002 and 2008 US Preventive …

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

RK Nam, R Saskin, Y Lee, Y Liu, C Law… - The Journal of …, 2010 - auajournals.org
Purpose: Transrectal ultrasound guided prostate biopsy is widely used to confirm the
diagnosis of prostate cancer. The technique has been associated with significant morbidity …

An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy

MA Liss, B Ehdaie, S Loeb, MV Meng… - The Journal of …, 2017 - auajournals.org
Purpose: In this white paper update we identify and discuss the prevalence and prevention
of common complications of prostate needle biopsy. Materials and Methods: A literature …